Nextcure to present at the 7th annual truist securities life sciences summit

Beltsville, md., april 28, 2021 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the 7th annual truist securities life sciences summit on may 5th at 2:40 pm eastern time.
NXTC Ratings Summary
NXTC Quant Ranking